Recticel SA/NV
RCZ.F
12.96 EUR
1 day: +3.18% (+0.40 EUR)
The alert is saved directly without jumping back to the homepage.
Price alerts for RCZ.F
Please log in to view and save price alerts.
Finanzen
Company info
Recticel SA/NV, an insulation company, provides thermal and thermo-acoustic solutions in Belgium, France, the Netherlands, Germany, France, Slovenia, other European Union countries, the United Kingdom, the United States, the European Union, and internationally. It offers thermal insulation boards comprising high-performance polyisocyanurate (PIR) foam used in various residential and non-residential applications; thermal acoustic insulation boards for partition wall applications; and vacuum insulation solutions for building and construction, cold chain packaging, and transportation sectors. The company also provides insulated panels, including mineral wool insulated panels; modular units, such as floor, column, and ceiling structural elements for use in a range of applications, including commercial, hospitality, education and industrial facilities; and PIR and mineral wool insulated panels. In addition, it offers products, such as absorption materials, barrier engineered solutions, damping products, gasketing solutions for metal or structural components, and thermal solutions; Soundcoat 360 solution, an acoustic engineering solution that leverages a host of products and services to market and minimize design costs for industrial spaces and original equipment manufacturing applications; and lab services and testing solutions. The company serves aerospace and aviation, heavy duty and transport vehicles, industrial equipment, electronic equipment and energy infrastructure, building and commercial construction, and medical equipment markets. It offers thermal acoustic boards under the Simfocor brand; and insulated panels under the Trimo, Trimo MSS, and REX Panels & Profiles brand names. The company was founded in 1896 and is headquartered in Brussels, Belgium.
Aktuelle News
-
Bekaert: Update on the Share Buyback Program and the Liquidity Agreement
Vorschau anzeigen
Update on the Share Buyback Program and the Liquidity Agreement Period from 20 August 2026 to 26 August 2026 Share Buyback ProgramOn 26 February 2026, Bekaert announced the start of the next tranche of its share buyback program, for a total maximum consideration of up to € 75 million. As announced previously, the purpose of the Program is to cancel all shares repurchased. Bekaert announces today that during the period from 20 August 2026 to 26 August 2026, Kepler Cheuvreux SA on behalf of Bekaer
-
Bank Handlowy w Warszawie SA (FRA:6HW) (Q2 2026) Earnings Call Highlights: Strong ROE and ...
Vorschau anzeigen
Bank Handlowy w Warszawie SA (FRA:6HW) reports PLN 321 million net profit with 21% ROE, marking a successful transition to its 'Bank for Global Business' strategy.
-
Touax: share capital and voting rights at 31072026
Vorschau anzeigen
REGULATED INFORMATION Paris, 27 August 2026 5:45 PM YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION Disclosure of Share Capital and Voting Rights Disclosure of Share Capital and Voting Rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. Register name of the issuer: TOUAX SCA (Euronext Growth Paris: ALTOU) DateTotal shares outstandingTotal voting rightsTotal exercisable voting ri
-
Van Lanschot Kempen NV (FRA:VA3) (H1 2026) Earnings Call Highlights: Record Inflows and NII ...
Vorschau anzeigen
Van Lanschot Kempen NV (FRA:VA3) surpasses EUR200 billion in client assets, raises full-year net interest income guidance, and showcases AI-driven efficiency gains.
-
Bittium launches new Faros Pro™ ECG device and EasyFlex™ single-use electrode patch for long-term ambulatory ECG monitoring
Vorschau anzeigen
Bittium today launches Bittium Faros Pro™, a new ambulatory ECG device designed for long-term ECG recording, together with Bittium EasyFlex™, a single-use one-lead electrode patch. Faros Pro marks a significant new ambulatory ECG device launch for Bittium outside the United States. It is also an important step in renewing the company's product portfolio and strengthening its international ECG offering.